Muscle attenuation, not skeletal muscle index, is an independent prognostic factor for survival in gastric cancer patients with overweight and obesity

Skeletal muscle index (SMI) is insufficient for evaluating muscle in obesity and muscle attenuation (MA) may be a preferred indicator. We aim to investigate whether MA has greater prognostic value than SMI in gastric cancer patients with overweight and obesity. Clinical parameters of 1312 patients with gastric cancer who underwent radical gastrectomy were prospectively collected between 2013 and 2019. MA and SMI were analyzed by computed tomography scan. Overweight and obesity was defined as body mass index (BMI) ≥ 24. The hazard ratio (HR) for death was calculated using Cox regression analysis. Among all patients, 405 were identified as overweight and obese and 907 were identified as normal and underweight. MA was inversely associated with BMI and visceral fat area. Among the 405 patients with overweight and obesity, 212 patients (52.3%) were diagnosed with low MA. In the overweight/obese group, MA was an independent predictor for overall survival (OS) (HR, 1.610; P = 0.021) in multivariate Cox regression analyses, while SMI did not remain in the model. In the normal/underweight group, both low MA (HR, 1.283; P = 0.039) and low SMI (HR, 1.369; P = 0.008) were independent factors of OS. Additionally, 318 patients were identified as having visceral obesity in the overweight/obese group and low MA was also an independent prognostic factor for survival in these patients (HR, 1.765; P = 0.013). MA had a higher prognostic value than SMI in overweight and obese patients with gastric cancer after radical gastrectomy.